In this post on USAID’s “IMPACTblog,” Christina Lau, USAID health officer for Central Asia, discusses tackling tuberculosis (TB) in migrant populations, writing, “Most migrants are unable to access the health care system because they are undocumented laborers, who lack proper identification documents required for health care treatment, and who fear deportation if their documentation status becomes known.” She notes, “USAID is working in coalition with government and international partners in order to improve access to TB services and treatment for this crucial population” (1/26).
“For the first time in India, 12 people have been detected with totally drug-resistant lung tuberculosis (TDR-TB), a condition in which patients do not respond to any TB medication” and for which the mortality rate is 100 percent, the Hindustan Times reports. “Doctors treating these patients say the absolute resistance is a result of the patients being prescribed wrong antibiotics,” the newspaper reports (1/7). “While Iran first reported TDR-TB cases three years ago, India seems to be only the second country to report this deadly form of the disease,” the Times of India notes (Iyer, 1/7).
The Los Angeles Times’ “Booster Shots” blog features an interview with Otto Yang, a professor at the Geffen School of Medicine at UCLA, who speaks about drug-resistant tuberculosis (TB) and the implications of a highly drug-resistant strain found in India. Yang said, “Obviously [the drug-resistant TB] could be devastating if it spreads, because treatment options are so limited. So far it seems not to have been as contagious as other strains, possibly because the mutations required to make it drug-resistant also make it a little less virulent” (Brown, 1/18).
“As the Global Fund [to Fight AIDS, Tuberculosis and Malaria] turns 10 on January 26, 2012, Nigerian families should join in the celebration of this innovative initiative that has saved the lives of millions here in Nigeria and across the globe,” Bello Bissalla, project manager for private sector and government partnerships at Friends of the Global Fund Africa, writes in Nigeria’s BusinessDay. “Much of the Global Fund’s success could be attributed to its performance-based financing mechanism, which creates room for transparency in the purchase, distribution and administration of drugs for these three diseases,” Bissalla continues, noting the grant review process “ensures that grant recipients show verified evidence of performance before receiving the next tranche of funding, thus ensuring transparency and implementation of the grant according to the plan.”
Small, Ingestible Sensor Can Track Patient Medication Intake, Activity Levels; Technology To Be Tested For TB Treatment
The FDA last month approved for use a small ingestible sensor that, when embedded into a pill, can help “keep track of whether a patient is taking their medicine on time,” Reuters reports. “The digital feedback technology, devised by Redwood City, California-based Proteus Digital Health Inc., can also prompt patients to take their medicine and even ask them to take a walk if they have been inactive for too long,” the news service writes. “Proteus has a partnership with the Bill & Melinda Gates Foundation and China’s Center for Disease Control and Prevention to test the technology in tuberculosis treatment,” Reuters notes, adding, “Pills for anything from the common cold to diabetes or cancer can be embedded.”
Health workers with Medical Teams International, a medical non-governmental organization, “say they are overwhelmed” by high demand at five health clinics in two southwestern Ugandan refugee centers, PlusNews reports. The refugees, “many of whom came from conflict-prone areas of the Democratic Republic of Congo (DRC),” and local residents are in need of HIV and tuberculosis (TB) prevention information, and care and treatment services, according to the news service. “Uganda suffers from a chronic shortage of health workers — less than half of the vacant health positions are filled — but the recent influx of refugees fleeing violence in neighboring DRC has put even more pressure on [the region’s] health services,” PlusNews writes. Physicians, who see 30 to 50 patients daily and often work double shifts, say gaps in the supplies of antiretroviral (ARV) and TB drugs poses concern, as does trying to follow-up with patients who may not return for visits, the news service notes (3/29).
The Center for Global Health Policy’s “Science Speaks” blog reports the findings from the second edition of the 2011 Report on Tuberculosis (TB) Research Funding and Trends from 2005-2010, released Thursday by Treatment Action Group (TAG) and the Stop TB Partnership. “TB research and development investment increased 76 percent between 2005 and 2010, but investment has slowed markedly, with only two percent growth since 2009,” the blog notes, adding, “The $630.4 million 2010 investment is only one-third of the $2 billion needed to stay on track with the Global Plan to Stop TB 10-year implementation and research strategy to eliminate TB as a public health threat by 2050” (Mazzotta, 3/28).
In this post in Huffington Post’s “Impact” blog, Deborah Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, examines “the success of U.S. efforts to promote better global health through support for [PEPFAR] and the Global Fund to Fight AIDS, Tuberculosis and Malaria.” She highlights U.S. Secretary of State Hillary Clinton’s recent trip to Africa, writing that Clinton’s “encouraging words” at the Reach Out Mbuya health center in Uganda reinforced U.S. commitment to an AIDS-free generation. She notes both PEPFAR and the Global Fund have supported the center and adds that “through hundreds of similar local programs all over the world, the Global Fund provides treatment to 3.6 million people who are HIV-positive.”
“Over the next few weeks, appropriators will be engaged in the challenging task of evaluating U.S. foreign assistance funding, including how effectively Congress’ global health investments are being used,” Charles Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation; Molly Joel Coye, interim president and CEO of PATH; Carolyn Miles, president and CEO of Save the Children; and Richard Stearns, president of World Vision, write in this Roll Call opinion piece. They continue, “As organizations funded in part by the U.S. government to implement global health programs in the field,” we “see firsthand how U.S. global health programs are working, and why now is not the time to cut multilateral and bilateral funding for these efforts.”
Secretary of State Hillary Clinton reflects on changes in U.S. global health diplomacy since taking office in this Global Health and Diplomacy opinion piece. “America had been leading the global health fight for decades,” but “we recognized that to sustain the impact of our work, we needed to change the way we did business,” she writes. “For example, while our agencies were providing tremendous leadership in isolation, they could still do more to collaborate effectively,” she writes, adding, “[W]e weren’t doing enough to coordinate our efforts with other donors or our partner countries,” and “we weren’t building sustainable systems to eventually allow our partner countries to manage more of their own health needs.” She says, “We were unintentionally putting a ceiling on the number of lives we could save.”